SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENT OF ENTHESITIS IN PATIENTS WITH ANKYLOSING SPONDYLITIS: POOLED ANALYSIS OF FOUR PIVOTAL PHASE 3 STUDIES

被引：0

作者：

Barkham, Nick ^{[1
]}

Schett, Georg ^{[2
]}

Baraliakos, Xenofon ^{[3
]}

van den Bosch, Filip ^{[4
]}

Deodhar, Atul ^{[5
]}

Gensler, Lianne S. ^{[6
]}

Ostergaard, Mikkel ^{[7
]}

Agawane, Shital ^{[8
]}

Gupta, Ayan Das ^{[8
]}

Mpofu, Shephard ^{[9
]}

Fox, Todd ^{[10
]}

Winseck, Adam ^{[10
]}

Shete, Abhijit ^{[9
]}

Porter, Brian ^{[10
]}

机构：

[1] New Cross Hosp, Rheumatol, Wolverhampton, England

[2] Univ Erlangen Nurnberg, Dept Med Rheumatol & Immunol, Erlangen, Germany

[3] Ruhr Univ Bochum, Rheumazentrum Ruhrgebiet, Herne, Germany

[4] Ghent Univ Hosp, Dept Rheumatol, Ghent, Belgium

[5] Oregon Hlth & Sci Univ, Div Arthrit & Rheumat Dis, Portland, OR 97201 USA

[6] Univ Calif San Francisco, Ankylosing Spondylitis Clin, San Francisco, CA 94143 USA

[7] Univ Copenhagen, Copenhagen Ctr Arthrit Res COPECARE, Copenhagen, Denmark

[8] Novartis Healthcare Pvt Ltd, Hyderabad, Telangana, India

[9] Novartis Pharma AG, Immunol Hepatol & Dermatol Dept, Basel, Switzerland

[10] Novartis Pharmaceut, Immunol Hepatol & Dermatol Dept, E Hanover, NJ USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

EP38

引用

页数：1